| PERIOD ENDING | 30-Oct-09 | 31-Jul-09 | 24-Apr-09 | 23-Jan-09 | | Total Revenue | 3,838,000 | 3,933,000 | 3,829,000 | 3,494,000 | | Cost of Revenue | 922,000 | 966,000 | 932,000 | 848,000 | | | Gross Profit | 2,916,000 | 2,967,000 | 2,897,000 | 2,646,000 | | | Operating Expenses | | Research Development | 369,000 | 370,000 | 368,000 | 337,000 | | Selling General and Administrative | 1,547,000 | 1,368,000 | 970,000 | 1,601,000 | | Non Recurring | (166,000) | 602,000 | 1,103,000 | 72,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,166,000 | 627,000 | 456,000 | 636,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 38,000 | (356,000) | 348,000 | | Earnings Before Interest And Taxes | 1,007,000 | 665,000 | 100,000 | 984,000 | | Interest Expense | (104,000) | 104,000 | 52,000 | 52,000 | | Income Before Tax | 1,111,000 | 561,000 | 48,000 | 932,000 | | Income Tax Expense | 242,000 | 116,000 | (80,000) | 209,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 869,000 | 445,000 | 128,000 | 723,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 869,000 | 445,000 | 128,000 | 723,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $869,000 | $445,000 | $128,000 | $723,000 |
|
0.51% Nasdaq 
0.28 (0.63%) 
Income Statement
